TORONTO, ONTARIO--(Marketwired - Apr 30, 2013) - Trimel Pharmaceuticals Corporation (TRL.TO) (the "Company" or "Trimel") proudly announced today that the Company has submitted a New Drug Application ("NDA") to the United States Food and Drug Administration ("FDA") for approval of its bioadhesive intranasal gel testosterone product, indicated for the treatment of testosterone deficiency in men ("CompleoTRT"). The CompleoTRT NDA is supported by efficacy and safety results from 306 patients who participated in the pivotal Phase III study.
"This NDA filing is an important achievement for Trimel," said Tom Rossi, President and Chief Executive Officer of Trimel. "If approved, CompleoTRT will provide men suffering from "Low T" with a novel treatment option. CompleoTRT is expected to offer hypogonadal patients the lowest efficacious delivered dose of testosterone in a convenient discreet device, without the risk for secondary transference."
The Company expects the CompleoTRT NDA will be subject to a standard review by the FDA, which could be completed as early as the first half of 2014.
About CompleoTRT
Trimel's most advanced product candidate, CompleoTRT, is a bioadhesive intranasal gel formulation of testosterone. CompleoTRT is designed with a view to providing hypogonadal patients with superior safety and enhanced convenience over currently available treatment options.
Subject to FDA approval, CompleoTRT is designed to be applied to the interior lateral wall of the nasal cavity, where internal studies have demonstrated that the gel is fully absorbed into the nasal mucosa within 15-30 minutes. There is virtually no smell or taste associated with the gel. It is expected that, as a result of the "no touch" targeted delivery to the nasal mucosa, CompleoTRT should avoid skin-to-skin transference to spouses or other family members, a health risk that led the FDA to issue a "black-box" warning in May 2009 for secondary transference for all topical testosterone gel preparations.
About Trimel
Trimel Pharmaceuticals Corporation (TRL.TO) - Trimel is a specialty pharmaceutical company actively developing medications for male hypogonadism, female sexual dysfunction and various respiratory disorders. For more information, please visit http://www.trimelpharmaceuticals.com.
Notice regarding forward-looking statements:
Information in this press release that is not current or historical factual information may constitute forward looking information within the meaning of securities laws. Implicit in this information, are assumptions regarding our future operational results. These assumptions, although considered reasonable by the Company at the time of preparation, may prove to be incorrect. Readers are cautioned that actual performance of the Company is subject to a number of risks and uncertainties (including, whether the Company will be successful in obtaining FDA approval of the CompleoTRT), and could differ materially from what is currently expected as set out above. For more exhaustive information on these risks and uncertainties you should refer to our prospectus dated April 18, 2013 which is available at http://www.sedar.com. Forward-looking information contained in this press release is based on our current estimates, expectations and projections, which we believe are reasonable as of the current date. You should not place undue importance on forward-looking information and should not rely upon this information as of any other date. While we may elect to, we are under no obligation and do not undertake to update this information at any particular time, whether as a result of new information, future events or otherwise, except as required by applicable securities law.
See the original post:
Trimel Submits New Drug Application for CompleoTRT(TM) to FDA
- The truth about guys and sex: They fake it, too - April 29th, 2013 [April 29th, 2013]
- Rock-It Man male sexual performance drug recalled - April 29th, 2013 [April 29th, 2013]
- Judge approves class-action lawsuit over erectile dysfunction link to prostate, baldness drugs - April 29th, 2013 [April 29th, 2013]
- Apricus, Innovus tackle bedroom disorders - April 29th, 2013 [April 29th, 2013]
- Ask Dr. K: Precautions for male bicyclists - April 29th, 2013 [April 29th, 2013]
- Advanced Male Medical Center Announces Hiring of Erick Salazar - April 29th, 2013 [April 29th, 2013]
- Faking the big O - April 29th, 2013 [April 29th, 2013]
- Priapus Shot - Video - April 29th, 2013 [April 29th, 2013]
- 4 Bio Stocks to Buy Today - May 1st, 2013 [May 1st, 2013]
- Class-Action Lawsuit on Propecia Erectile Dysfunction Approved: Now, AttorneyOne Can Provide Advice - May 3rd, 2013 [May 3rd, 2013]
- Trimel to Report First Quarter 2013 Results and Host Investor Call - May 3rd, 2013 [May 3rd, 2013]
- Acupuncture Presentation Part 2 - Video - May 6th, 2013 [May 6th, 2013]
- Sixty-One Per Cent of Women Say their Sex Lives are Suffering Due to a Condition of Menopause - May 7th, 2013 [May 7th, 2013]
- Apricus Biosciences Announces Poster Presentation of Vitaros(R) Data in Men Previously Unresponsive to PDE-5 ... - May 8th, 2013 [May 8th, 2013]
- Dietary Supplement Lightning Rod Capsules Recall - May 8th, 2013 [May 8th, 2013]
- Apricus Biosciences Announces First Quarter 2013 Financial Results Conference Call - May 8th, 2013 [May 8th, 2013]
- BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Special Meetings of Stockholders to Consider Proposed Merger - May 9th, 2013 [May 9th, 2013]
- Why Wait? Enlast Personal Male Lubricant. Stop Premature Ejaculation In Its Tracks With Enlast.flv - Video - May 9th, 2013 [May 9th, 2013]
- Searching For Male Fountain of Youth? Go Exercise - May 11th, 2013 [May 11th, 2013]
- BioSante Pharmaceuticals, Inc. Reports First Quarter Financial Results - May 11th, 2013 [May 11th, 2013]
- Apricus Biosciences Provides First Quarter 2013 Corporate Update - May 11th, 2013 [May 11th, 2013]
- DGAP-News: Apricus Biosciences Provides First Quarter 2013 Corporate Update - May 11th, 2013 [May 11th, 2013]
- Sex and the elderly male - May 12th, 2013 [May 12th, 2013]
- Couple sues state over toddler's sexual-reassignment surgery - May 15th, 2013 [May 15th, 2013]
- Columbia couple sues state over toddler’s sexual-reassignment surgery - May 15th, 2013 [May 15th, 2013]
- If Sexual Dysfunction Were a Virus, "It'd Be Pandemic": Expert - May 16th, 2013 [May 16th, 2013]
- Couple files groundbreaking lawsuit over child’s sexual-reassignment surgery - May 16th, 2013 [May 16th, 2013]
- The Dangers Lurking in Male Sexual Supplements - May 17th, 2013 [May 17th, 2013]
- West Jordan man pleads guilty to falsely advertising, selling Viagra-like drug - May 17th, 2013 [May 17th, 2013]
- Manning up to the church - May 20th, 2013 [May 20th, 2013]
- Boy who manned up to the church - May 20th, 2013 [May 20th, 2013]
- The low-down on erectile problems - May 21st, 2013 [May 21st, 2013]
- Study: Genital Warts May Lead to Sexual Dysfunction; polyDNA Recommends Gene-Eden-VIR Against the Genital Warts Virus - May 22nd, 2013 [May 22nd, 2013]
- Quit smoking for a better sex life - study - May 22nd, 2013 [May 22nd, 2013]
- If It Doesn’t Make Us Nymphos, Female Viagra Will Save Monogamy - May 23rd, 2013 [May 23rd, 2013]
- Erectile dysfunction drugs sold as herbal medicine - May 24th, 2013 [May 24th, 2013]
- Heart failure ups risk of male menopause 4 fold - May 25th, 2013 [May 25th, 2013]
- Heart failure accelerates male 'menopause' - May 25th, 2013 [May 25th, 2013]
- New Asia-Pacific Sexual Satisfaction Study Pulls Back the Covers on Relationship Tension Facing Couples - May 28th, 2013 [May 28th, 2013]
- Heart Disease Accelerates Male Menopause - May 29th, 2013 [May 29th, 2013]
- Igniting woman's sexual desire is more than popping pill - May 30th, 2013 [May 30th, 2013]
- Warning: 'Natural' sex supplements may not be - May 31st, 2013 [May 31st, 2013]
- Dangers of sex supplements - May 31st, 2013 [May 31st, 2013]
- Warning: Men's natural sex supplements may not be - May 31st, 2013 [May 31st, 2013]
- Sex is doctor's life's work - June 1st, 2013 [June 1st, 2013]
- Sex is life's work for doctor - June 3rd, 2013 [June 3rd, 2013]
- Sexual stress common in men - June 6th, 2013 [June 6th, 2013]
- Sexual performance anxiety - June 6th, 2013 [June 6th, 2013]
- Affirm XL, Inc. Re-launches U.S. Made Sexual Enhancement Dietary Supplement - June 6th, 2013 [June 6th, 2013]
- Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction - June 11th, 2013 [June 11th, 2013]
- DGAP-News: Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction - June 11th, 2013 [June 11th, 2013]
- BPA linked to obesity risk in puberty-age girls - June 13th, 2013 [June 13th, 2013]
- Baldness drug curbs interest in alcohol, study says- Fla. mom dies after butt enhancing injections - June 14th, 2013 [June 14th, 2013]
- Anti-baldness drug can cause men to lose interest in alcohol - June 14th, 2013 [June 14th, 2013]